Hemagen Diagnostics, Inc.
HMGN
$0.00
$0.000.00%
| 09/30/2012 | 06/30/2012 | 03/31/2012 | 12/31/2011 | 09/30/2011 | |
|---|---|---|---|---|---|
| Revenue | 875.90K | 947.80K | 1.11M | 1.11M | 1.15M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 875.90K | 947.80K | 1.11M | 1.11M | 1.15M |
| Cost of Revenue | 473.80K | 494.40K | 760.80K | 699.70K | 678.30K |
| Gross Profit | 402.10K | 453.50K | 350.50K | 407.30K | 467.90K |
| SG&A Expenses | 427.70K | 465.30K | 452.40K | 661.30K | 636.20K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 919.60K | 960.10K | 1.24M | 1.36M | 1.32M |
| Operating Income | -43.70K | -12.30K | -127.20K | -254.70K | -169.50K |
| Income Before Tax | -163.00K | -132.10K | -243.60K | -368.60K | -281.90K |
| Income Tax Expenses | -- | -- | -- | -- | 0.00 |
| Earnings from Continuing Operations | -163.00K | -132.10K | -243.60K | -368.60K | -281.90K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -163.00K | -132.10K | -243.60K | -368.60K | -281.90K |
| EBIT | -43.70K | -12.30K | -127.20K | -254.70K | -169.50K |
| EBITDA | -7.10K | 27.90K | -83.30K | -211.20K | -125.10K |
| EPS Basic | -0.01 | -0.01 | -0.02 | -0.02 | -0.02 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.02 | -0.02 | -0.02 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 15.50M | 15.50M | 15.49M | 15.49M | 15.48M |
| Average Diluted Shares Outstanding | 15.50M | 15.50M | 15.49M | 15.49M | 15.48M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
